Alterations in NQO1 stability and function are associated to different extents with a variety of human diseases, including cancer, neurological disorders (such as Parkinson ́s and Alzheimer ́s diseases, multiple sclerosis and schizophrenia) and cardiovascular diseases [1,21]. This evidence concerns the gene NQO1 and early-onset autosomal dominant Alzheimer disease.